Dontated medicines for neglected tropical diseases have improved billions of lives
Working with national governments, the World Health Organization (WHO), and hundreds of partners, pharmaceutical companies have donated billion of drugs, invested in research & development and supported delivery efforts to stop Neglected Tropical Diseases.
Participating Companies
A Historic Public-Private Partnership
Since 2012, companies have donated more than 14 billion NTD treatments. As a result, more people than ever before receive at least one NTD drug: from 727 million in 2011 to more than 1.1 billion in 2019.
Since 2016, over 797 million individuals every year have received preventive chemotherapy (PC) interventions for at least one NTD.
In 2019 alone, pharmaceutical companies donated nearly 1.8 billion NTD treatments compared to 970 million in treatments in 2011.
Between 2010 and 2020, the number of people requiring treatment for at least one NTD fell from 2 billion to 1.7 billion, a drop of 300 million people.